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In GN4 rat liver epithelial cells, angiotensin II (Ang II) and other agonists which activate phospholipase C
stimulate tyrosine kinase activity in a calcium-dependent, protein kinase C (PKC)-independent manner. Since
Ang II also produces a proliferative response in these cells, we investigated downstream signaling elements
traditionally linked to growth control by tyrosine kinases. First, Ang II, like epidermal growth factor (EGF),
stimulated AP-1 binding activity in a PKC-independent manner. Because increases in AP-1 can reflect
induction of c-Jun and c-Fos, we examined the activity of the mitogen-activated protein (MAP) kinase family
members Erk-1 and -2 and the c-Jun N-terminal kinase (JNK), which are known to influence c-Jun and c-Fos
transcription. Ang II stimulated MAP kinase (MAPK) activity but only ;50% as effectively as EGF; again,
these effects were independent of PKC. Ang II also produced a 50- to 200-fold activation of JNK in a
PKC-independent manner. Unlike its smaller effect on MAPK, Ang II was approximately four- to sixfold more
potent in activating JNK than EGF was. Although others had reported a lack of calcium ionophore-stimulated
JNK activity in lymphocytes and several other cell lines, we examined the role of calcium in GN4 cells. The
following results suggest that JNK activation in rat liver epithelial cells is at least partially Ca21 dependent:
(i) norepinephrine and vasopressin hormones that increase inositol 1,4,5-triphosphate stimulated JNK; (ii)
both thapsigargin, a compound that produces an intracellular Ca21 signal, and Ca21 ionophores stimulated
a dramatic increase in JNK activity (up to 200-fold); (iii) extracellular Ca21 chelation with ethylene glycol
tetraacetic acid (EGTA) inhibited JNK activation by ionophore and intracellular chelation with 1,2-bis-(o-
aminophenoxy)-ethane-N,N,N*,N*-tetraacetic acid tetraacetoxymethyl-ester (BAPTA-AM) partially inhibited
JNK activation by Ang II or thapsigargin; and (iv) JNK activation by Ang II was inhibited by pretreatment of
cells with thapsigargin and EGTA, a procedure which depletes intracellular Ca21 stores. JNK activation
following Ang II stimulation did not involve calmodulin; neither W-7 nor calmidizolium, in concentrations
sufficient to inhibit Ca21/calmodulin-dependent kinase II, blocked JNK activation by Ang II. In contrast,
genistein, in concentrations sufficient to inhibit Ca21-dependent tyrosine phosphorylation, prevented Ang II
and thapsigargin-induced JNK activation. In summary, in GN4 rat liver epithelial cells, Ang II stimulates JNK
via a novel Ca21-dependent pathway. The inhibition by genistein suggests that Ca21-dependent tyrosine
phosphorylation may modulate the JNK pathway in a cell type-specific manner, particularly in cells with a readily
detectable Ca21-regulated tyrosine kinase.
Hormones which activate seven transmembrane receptors
such as bombesin, thrombin, and angiotensin II (Ang II) can
act as growth factors in some cell types (5, 25, 35). The mito-
genic pathways induced by these hormones depend upon the
class of G-proteins to which the receptor is coupled and the
downstream pathways activated by that G-protein. For exam-
ple, Gai may activate MEK kinase (MEKK) (29, 34) while Gaq
activates phospholipase C, stimulating diacylglycerol and cal-
cium-dependent pathways (2). The relative contributions of
the individual intracellular signals to the growth response may
also differ from cell type to cell type. For example, in some cell
types, a calcium signal is thought to be dispensable for growth
(6, 44, 48), but in other cell types, a rise in intracellular calcium
appears to be part of the proliferative signal (2, 60, 61).
In rat liver epithelial cells, Ang II stimulates proliferation.
Until recently, this was presumed to occur through G-protein-
dependent activation of protein kinase C (PKC) or calcium/
calmodulin-dependent enzymes, including calcium/calmodu-
lin-dependent kinase II. However, work from this laboratory
has added another potential mechanism leading to prolifera-
tion: an Ang II-dependent stimulation of tyrosine kinase ac-
tivity (24–26). In both normal (WB) and transformed (GN4)
rat liver epithelial cells, treatment with Ang II, vasopressin,
and a1 agonists results in rapid (15 to 60 s) tyrosine phosphor-
ylation of at least five proteins. This hormonally induced in-
crease in tyrosine kinase activity is blocked by calcium chela-
tors which prevent a rise in intracellular calcium and is
mimicked by agents that increase intracellular calcium concen-
trations. The Ang II-dependent increase in tyrosine kinase
activity is PKC independent. The tyrosine kinase regulated by
calcium in GN4 cells is likely to be a member of a novel family,
because it appears to be a cytosolic enzyme of 115 to 120 kDa.
This activity is not recognized by JAK1, JAK2, or JAK3 anti-
sera and can be clearly separated from pp125FAK activity (un-
published results). Other G-protein-coupled receptors have
also been shown to stimulate tyrosine phosphorylation in sev-
eral cell types (3, 13, 14, 38, 40, 45, 47, 53, 56, 66).
Tyrosine phosphorylation is a regulatory mechanism fre-
quently associated with cell growth and mitosis. Stimulation of
growth factor receptors such as the epidermal growth factor
(EGF) receptor results in tyrosine phosphorylation, stimula-
tion of the Ras pathway, and activation of a serine/threonine
kinase cascade that includes the mitogen-activated protein
(MAP) kinase (MAPK) family members Erk-1 and -2 (for a
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review, see reference 9). Activated MAPK in turn influences
gene expression by phosphorylating transcription factors such
as Elk-1 (16, 39). Other members of the MAPK family have
recently been identified in yeast and mammalian cells; one
group, referred to as the stress-activated protein kinases or the
c-Jun amino-terminal kinases (JNKs), has been cloned and
assigned a physiologic function (12, 23, 32). JNK1 was initially
identified as a 46-kDa kinase activity with an unusually high
affinity for its substrate, c-Jun. JNK1 and its 54-kDa related
JNK2 phosphorylate c-Jun on specific N-terminal serine resi-
dues (Ser-63 and Ser-73), leading to enhanced c-Jun transac-
tivation potential (57). Unlike Erk-1 and -2, the JNKs are
strongly activated by stimuli other than growth factor receptor
tyrosine kinases, including signals as diverse as UV irradiation
(12, 23), osmotic shock (15, 19), protein synthesis inhibitors,
hydrogen peroxide (32), and tumor necrosis factor alpha
(TNFa) stimulation (32, 62, 63). While the pathways of JNK
activation have not been fully delineated, these kinases are
only slightly activated by agents that primarily activate Raf/
MEK/MAPK (32, 43, 62). This suggests separate pathways
leading to JNK and MAPK activation, a divergence substanti-
ated by the isolation of SEK (also referred to as JNKK), a
dual-specificity kinase that directly activates JNK by phospho-
rylating the enzyme on a TPY motif (36, 54, 65), while MEK
activates Erk-1 and -2 by phosphorylating a TEY motif (49).
In rat liver epithelial cells, treatment with both Ang II and
EGF increased tyrosine phosphorylation and proliferation
(24–26). We now report that both Ang II and EGF increase
AP-1 binding as well as MAPK and JNK activation in a PKC-
independent manner. Particularly striking was a 200-fold acti-
vation of JNK by Ang II, a stimulation considerably greater
than that by EGF. Thus, unlike many ligands which stimulate
primarily either JNK (e.g., TNFa) or MAPK (e.g., EGF), Ang
II effectively stimulated both JNK and MAPK. In lymphocytes
and several other cell lines, a calcium signal did not increase
JNK activity (59). In contrast, Ang II-induced JNK activation
in GN4 cells is dependent on increases in calcium and is mim-
icked by agents that increase calcium. Analogous to Ang II’s
activation of tyrosine kinase activity in GN4 cells, JNK activa-
tion was PKC and calmodulin independent and was inhibited
by genistein. These parallels suggest that differential expres-
sion of a calcium-regulated tyrosine kinase may distinguish
those cell types in which a calcium signal, as a single stimulus,
can activate JNK.
MATERIALS AND METHODS
Materials. EGF was purified from mouse salivary glands as described previ-
ously (55). Human Ang II (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe) was obtained
from Sigma. Ang II was prepared in 50 mM acetic acid. EGF was prepared as
100-fold-concentrated solutions in 10 mM NaPi (pH 7.4)–150 mM NaCl con-
taining 0.1% bovine serum albumin (BSA). Phorbol 12-myristate 13-acetate
(TPA; Sigma), thapsigargin (Sigma), bis-(o-aminophenoxy)ethane-N,N,N9,N9-
tetraacetic acid, tetraacetoxymethyl ester (BAPTA-AM; Gibco-BRL), ionomy-
cin, and A23187 (Calbiochem) were prepared as stock solutions in dimethyl
sulfoxide (final concentration, #0.1% [vol/vol]). Polyclonal anti-ERK/MAPK
antiserum K-23 was obtained from Santa Cruz Biotechnology, and enhanced
chemiluminescence (ECL) reagents were from Amersham.
Cell culture. GN4 rat liver epithelial cells were grown at 378C in Richter’s
improved minimal essential medium with 0.1 mM insulin supplemented with 10%
fetal bovine serum (FBS) in a humidified 5% CO2 atmosphere as described
previously (24). Prior to agonist stimulation, cells were serum starved (0.5%
FBS) for 20 h and incubated for 18 h with 6 to 10 mM TPA or vehicle to deplete
cells of PKC.
Assessment of AP-1 activity. Nuclear extracts were prepared as described by
Sadowski and Gilman (52) with modifications. Briefly, confluent GN4 cells
(100-mm plate) were serum starved for 24 h (0.5% FBS) and treated for 18 h
with either 10 mM TPA or vehicle. Following treatment with EGF (300 ng/ml) or
Ang II (1 mM), cells were rinsed twice with ice-cold phosphate-buffered saline
(PBS), once with PBS containing 1 mM Na3VO4 and 20 mM NaF, and once with
hypotonic buffer (20 mM HEPES [N-2-hydroxyethylpiperazine-N9-2-ethanesul-
fonic acid, pH 7.9], 20 mM NaF, 1 mM Na3VO4, 1 mM Na4P2O7, 1 mM EDTA,
1 mM EGTA [ethylene glycol tetraacetic acid], 1 mM dithiothreitol [DTT], 0.5
mM phenylmethylsulfonyl fluoride [PMSF], 1 mg of leupeptin per ml, 4 kallikrein
inhibitor units [KIU] of aprotinin per ml). Cells were lysed by addition of 0.5 ml
of hypotonic buffer with 0.2% Nonidet P-40, and lysates were scraped into
Eppendorf tubes and centrifuged at maximum speed for 20 s. The pelleted nuclei
were resuspended in 120 ml of hypotonic buffer with 420 mM NaCl and 20%
glycerol added and rocked gently for 30 min at 48C. Soluble extracted nuclear
proteins were isolated by a 20-minute centrifugation at maximum speed.
Gel shift assays were performed as described before (1). Briefly, 10 mg of
nuclear extracts was incubated on ice for 15 min with 2 mg of poly
(dI z dC) z poly(dI z dC) in binding buffer (10 mM Tris [pH 7.9], 0.5 mM EDTA,
10% glycerol, 1 mM DTT, BSA), and then an excess of end-labeled AP-1 probe
(59TGAGGGTGATTCAGAGGCAGGTGCCCACAGTTTCAC TTC39; ;10,000
cpm) (17) was added, followed by incubation at room temperature for 20 min.
Binding to the radiolabeled probe was inhibited by addition of unlabeled oligo-
nucleotide to an AP-1 sequence. Reaction mixes were run on 5% nondenaturing
polyacrylamide gels and autoradiographed.
Preparation of GST fusion protein. pGEX2T-c-Jun (wild type), containing the
transactivation domain of c-Jun (amino acids 1 to 223), pGEX2T-c-Jun (Ala-63
and -73), and pGEX2T were described previously (23). This portion of c-Jun
contains the JNK binding domain and serine residues 63 and 73, which, when
phosphorylated, correlate with increased transcriptional activity of c-Jun. The
serine 63 and 73 residues are mutated to Ala in the c-Jun Ala protein, and the
mutated fusion protein serves as a control to determine increases in phosphor-
ylation at sites not associated with increased transcriptional activation. The
glutathione-S-transferase (GST)-protein expression vectors were transformed
into Escherichia coli DH5a. Proteins were purified as described by Pharmacia.
The amounts of purified proteins were estimated by sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE) and subsequent staining with
Coomassie blue. The appearance of a phosphorylated GST-c-Jun doublet is
produced by the full-length GST-c-Jun amino acids 1 to 223 [GST-c-Jun(1–223)]
and a proteolytic cleavage product containing approximately 80 N-terminal
amino acids. This lower band, created during purification of the fusion protein,
migrates similarly to a purified GST-c-Jun(1–79) construct.
Preparation of cell extracts. Cells were lysed with ice-cold new lysis buffer (20
mM sodium HEPES [pH 7.3], 50 mM NaF, 10% glycerol, 1% Triton X-100, 1
mMNa3VO4, 150 mMNaCl, 5 mM EDTA, 0.5 mM PMSF, 1 mg of leupeptin per
ml, 4 KIU of aprotinin per ml). Lysates were clarified by centrifugation at 14,000
3 g for 15 min at 48C.
In vitro JNK assay. In vitro kinase assays were carried out as previously
described with GST-c-Jun linked to Sepharose beads as the substrate (23).
Briefly, 50 mg of cell extracts was incubated with 10 mg of GST, GST-c-Jun, or
GST-c-Jun(Ala) and 300 ml of HEPES binding buffer (20 mM HEPES [pH 7.7],
50 mM NaCl, 2.5 mM MgCl2, 0.1 mM EDTA, 0.5% Triton X-100). The mixture
was then rotated for 2 h in a microcentrifuge tube. After the incubation, protein
was pelleted by centrifugation at 14,000 3 g for 2 min. JNK binds to the
transactivation domain of c-Jun and is precipitated with the GST-c-Jun. After
four washes in 1 ml of HEPES binding buffer, the pelleted beads were resus-
pended in 30 ml of kinase buffer (20 mMHEPES [pH 7.6], 20 mMMgCl2, 20 mM
b-glycerophosphate, 20 mM p-nitrophenyl phosphate, 0.1 mM Na3VO4, 2 mM
DTT) containing 0.5 mCi of [g-32P]ATP (40 mM ATP). Samples were incubated
for 20 min at 308C and chilled, and excess kinase buffer was removed. Phosphor-
ylated proteins were eluted by boiling with 7 ml of 33 concentrated SDS sample
buffer (26) and resolved on an SDS–10% PAGE gel, followed by autoradiogra-
phy and phosphorimage analysis. The consistency of GST-c-Jun protein recovery
was monitored by examination of the Coomassie blue-stained protein in each gel
lane.
MAPK activation assays. Activation of MAPK was determined as described
previously (62). Briefly, 10 ml of 33 sample buffer was added to 45 mg of cell
lysate, and extracts were resolved on an SDS–15% PAGE gel. Proteins were then
transferred to nitrocellulose membranes for analysis by Western blotting (im-
munoblotting) with the rabbit anti-ERK/MAPK antiserum K-23 (Santa Cruz
Biotechnology) to detect p42 MAPK and p44 MAPK. Blots were probed with a
secondary donkey anti-rabbit immunoglobulin antibody conjugated to horserad-
ish peroxidase, and immunoreactive proteins were visualized by using ECL
reagents (Amersham).
Phosphotyrosine immunoblotting. Cells incubated for 15 min with or without
genistein at various doses were treated with EGF (300 ng/ml) or Ang II (0.1 mM).
At 1 min, the cells were lysed in detergent-containing buffer, clarified by cen-
trifugation in a microcentrifuge, boiled in SDS sample buffer, separated by 8%
PAGE, and transblotted to nitrocellulose (26). Antiphosphotyrosine immuno-
blotting was performed with monoclonal antibody PT66 (Sigma) as described
before (26).
RESULTS
Ang II increases PKC-independent AP-1 binding.We exam-
ined the changes affecting gene expression associated with the
Ang II-dependent tyrosine phosphorylation and proliferative
responses. First, the effect of Ang II treatment on AP-1 DNA
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binding was assessed by a gel shift assay as described in Ma-
terials and Methods. AP-1 binding was increased within 30 min
of Ang II stimulation (data not shown). Ang II stimulation can
activate PKC, which by itself increases AP-1 binding. To de-
termine if Ang II-dependent AP-1 activity was due to PKC
activation, cells were treated for 18 h with phorbol ester (10
mM TPA), which depletes TPA-sensitive PKC activity (22) and
abolishes the PKC-dependent activation of MAPK in these
cells (see Fig. 2 below). In serum-starved, TPA-treated cells,
EGF-induced AP-1 binding was detected beginning at 30 min
and remained elevated for 120 min. Similar to EGF, Ang
II-induced AP-1 binding was detected at 30 min; however,
AP-1 activity peaked at 60 min and declined by 120 min (Fig.
1). Ang II-induced AP-1 binding at 60 min was slightly less
than EGF-induced binding at 60 min.
Ang II stimulation leads to PKC-independent activation of
MAPK. MAPK activation can lead to increased AP-1 binding
via increases in c-Fos expression (see reference 30 for a re-
view). To determine if Ang II stimulation increases MAPK
activation, GN4 cells were stimulated with Ang II or EGF.
After lysis, the phosphorylation state of MAPK was assessed in
a gel mobility shift assay by subjecting cell extracts to Western
blot analysis with anti-Erk-1 and -2 antibodies. Phosphoryla-
tion of MAPK was detected as a shift in mobility and is highly
correlated with increased MAPK activity. Ang II stimulation
resulted in activation of MAPK at 5 min (Fig. 2).
PKC can activate the MAPK pathway, and Ang II activates
PKC. In order to determine if PKC mediated Ang II-induced
MAPK activation, cells were depleted of PKC by overnight
TPA treatment. The right panel of Fig. 2 demonstrates that a
short (5 min) TPA treatment stimulated MAPK in GN4 cells.
This stimulation was abolished by an 18-h TPA treatment,
confirming the loss of TPA-sensitive isoforms of PKC. In con-
trast, EGF- or Ang II-induced MAPK activation was equiva-
lent or only slightly diminished in PKC-depleted cells, indicat-
ing that both Ang II and EGF increase MAPK activity at least
partly by PKC-independent mechanisms. These results were
confirmed by MAP kinase assays in which Erk-1 was immuno-
precipitated with specific antibodies and used in an immune
complex kinase activity with myelin basic protein as the sub-
strate (data not shown).
In TPA-treated cells, Ang II stimulated both Erk-1 and -2
within 1 min; activation was nearly maximal at 5 min (data not
shown). The percent stimulation of MAPK phosphorylation by
Ang II was variable but was always less than that produced by
EGF. In general, the activation induced by Ang II was approx-
imately 50% of that by EGF. Activation of MAPK by Ang II
requires tyrosine kinase activity. Stimulation of MAPK by both
Ang II and EGF was blocked by the tyrosine kinase inhibitor
genistein (Fig. 2, second and third panels). This concentration
of genistein (600 mM) totally inhibited Ang II-stimulated ty-
rosine kinase activity (see Fig. 9B).
Ang II stimulation leads to PKC-independent activation of
JNK. Activation of JNK can also increase AP-1 binding by
increasing the transactivation potential of c-Jun and ATF-2,
leading to induction of c-Jun (12, 18). Therefore, we tested the
effect of Ang II on JNK activation in a solid-state kinase assay
with GST fused to the N-terminal 223 amino acids of c-Jun as
a substrate. In our preparation, a portion of this fusion protein
is proteolyzed, cleaving approximately all but the first 79 amino
acids of the c-Jun N terminus. Both forms of the fusion protein
contain Ser-63 and Ser-73, which are phosphorylated by JNK.
A similar fusion protein with Ser-63 and Ser-73 of c-Jun mu-
tated to alanine [c-Jun(Ala)] was used to assess the specificity
of the JNK kinase activity. JNK binds with high affinity to the
c-Jun N terminus and can then be precipitated with the GST-
Jun substrate and separated from nonspecific kinases by a
low-speed centrifugation. Serum-starved, TPA-treated cells
were stimulated with Ang II for 1 to 90 min and lysed. Ang II
increased JNK kinase activity, and the activity was greater
FIG. 1. Ang II and EGF induce AP-1 binding. GN4 cells were treated with 10
mMTPA for 18 h. Nuclear extracts were prepared from cells stimulated with Ang
II or EGF for the indicated times. Extracts were incubated with labeled AP-1
oligonucleotide probe and subjected to nondenaturing gel electrophoresis fol-
lowed by autoradiography, as described in Materials and Methods. AP-1 binding
is indicated by the upper arrow, and free probe is indicated by the lower arrow.
The nonspecific binding in the mid-gel region (not inhibited by unlabeled AP-1
oligonucleotides) indicates the even loading of the gel. Data are representative
of three experiments.
FIG. 2. Ang II stimulation activates both Erk-1 and -2. GN4 cells were (1)
or were not (2) treated with 10 mM TPA for 18 h to deplete PKC or with
genistein for 15 min to inhibit tyrosine kinase activity. Cells were stimulated for
5 min with vehicle, Ang II (1 mM), EGF (300 ng/ml), or TPA (100 nM). Lysates
were run on SDS-PAGE gels and MAPK immunoblotted. Unphosphorylated
Erk-1 and -2 are indicated by the arrows marked 44 and 42 kD, respectively.
Asterisks denote the mobility-shifted form of these two Erks.
FIG. 3. Ang II stimulation activates JNK. (A) TPA-treated GN4 cells were
stimulated with Ang II (1 mM) for 30 min, and cell lysates were used for the in
vitro kinase assay with GST-c-Jun or GST-c-Jun(Ala) as the substrate. (B)
TPA-treated GN4 cells were stimulated with Ang II (1 mM) or EGF (300 ng/ml)
for the indicated times. Cell lysates were used for in vitro kinase assays with
GST-c-Jun as the substrate as described in Materials and Methods.
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when assayed with the wild type than with the Ala-mutated
substrate (Fig. 3A). As shown in Fig. 3B, Ang II stimulation of
JNK kinase activity peaked between 30 and 60 min and de-
clined by 90 to 120 min. The fold activation of JNK by Ang II
stimulation was dependent on the background activity but
ranged from 40- to 200-fold. This massive fold activation is due
in part to the low background of JNK activity in these epithelial
cells, a background that appears to differ from the higher basal
activity seen in cultured fibroblasts and other cell types re-
ported in the literature. The induction by Ang II was generally
four- to sixfold greater than activation by EGF (Fig. 3B). The
significant activation of both JNK and MAPK (Fig. 2 and 3) by
Ang II was somewhat surprising, given the fact that many
ligands predominantly activate only one of the MAPK family
members (32, 62).
Norepinephrine and vasopressin are two agonists that bind
to G-protein-coupled receptors, leading to increases in intra-
cellular Ca21 levels and tyrosine phosphorylation in GN4 cells.
A 30-min treatment with either agonist (norepinephrine [10
mM] or vasopressin [1 mM]) increased JNK kinase activity by
an amount comparable to that by Ang II (data not shown).
These data suggest that in GN4 cells, JNK activation is a
common downstream effector to agonists which increase intra-
cellular Ca21 levels.
In other cell types, PKC does not substantially activate JNK
(43); however, we investigated its role in GN4 cells because
Ang II, norepinephrine, and vasopressin all activate PKC.
Short (5 min) TPA stimulation consistently activated MAPK
(e.g., see Fig. 2); however, when assayed in the same cell
lysates, JNK activity was not significantly increased (data not
shown). In fact, in cells depleted of PKC by TPA treatment,
JNK activation in response to Ang II was greater than that in
non-TPA-treated cells (Fig. 4). This is probably due to an
absence of PKC-dependent downregulation of the Ang II re-
sponse at the receptor or G-protein level, a phenomenon that
we had previously observed in rat liver epithelial cells (22).
A calcium signal activates JNK in GN4 cells. Ang II stim-
ulation leads to transient increases in intracellular calcium
levels, and this calcium signal mediates Ang II-dependent in-
creases in tyrosine kinase activity (24, 26). Stimulation of ty-
rosine kinase activity in GN4 cells is mimicked by increasing
intracellular calcium levels by using either calcium ionophores
or thapsigargin. Additionally, norepinephrine and vasopressin,
which increase intracellular calcium, also increase JNK activ-
ity, suggesting that calcium may participate in JNK activation.
To define the role of calcium in JNK activation, TPA-treated
GN4 cells were stimulated for the indicated times with Ang II
or thapsigargin (an agent that prevents reuptake of intracellu-
lar calcium into storage vessicles and thus produces an intra-
cellular calcium signal [25]). JNK activity increased in response
to thapsigargin but was slightly delayed compared with that
after Ang II treatment (Fig. 5A and B), as for the thapsigargin-
induced intracellular calcium signal (25). In multiple experi-
ments in which Ang II and thapsigargin were directly com-
pared, the thapsigargin effect ranged from approximately 40 to
120% (e.g., Fig. 5A and B) of that of Ang II, suggesting that
Ang II-induced calcium increases may be in part responsible
for JNK activation. In contrast, when MAPK and JNK activa-
tion were analyzed with the same cell lysates, thapsigargin only
minimally activated MAPK at 5 or 30 min, while Ang II clearly
activated MAPK (unpublished results).
To further test for the role of calcium in JNK activation,
TPA-treated GN4 cells were incubated with the calcium iono-
phore A23187 for the indicated times (Fig. 6A). A23187 stim-
FIG. 4. TPA treatment enhances Ang II activation of JNK. GN4 cells were
treated for the indicated times (E) or not treated (F) with TPA (10 mM) and
then stimulated with Ang II (1 mM). Cell extracts were used in an in vitro kinase
assay with GST-c-Jun as a substrate. Incorporation of [g-32P]ATP was quanti-
tated by phosphorimage analysis and is expressed in arbitrary units.
FIG. 5. Thapsigargin treatment activates JNK. TPA-treated GN4 cells were
stimulated with Ang II or thapsigargin (1 mM) for the indicated times (in minutes
or hours). Cell lysates were used in an in vitro kinase assay with GST-c-Jun as the
substrate. Panels A and B represent two different experiments, showing the range
and time course of JNK activation by thapsigargin.
FIG. 6. Calcium ionophores activate JNK. (A) TPA-treated GN4 cells were
stimulated with A23187 (10 mM) for the indicated times, and JNK activity was
assessed as described in Materials and Methods. (B) TPA-treated cells were
stimulated with 10 mM A23187 or ionomycin for 30 min, and JNK activity was
assessed as described in Materials and Methods.
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ulated JNK, with increased kinase activity detectable at 15 min,
peaking between 30 and 45 min, and declining by 60 min. JNK
activation by A23187 (or ionomycin) was comparable to that by
Ang II (up to 200-fold; see Fig. 7). The dose response of JNK
activation to A23187 and ionomycin is shown in Fig. 6B. Both
A23187 and ionomycin increase JNK kinase activity at 0.01
mM; an effect of ionomycin was seen at doses as low as 0.001
mM. The maximal effect seen at 1 mM ionomycin was lost at
higher doses, presumably because of a toxic effect. The highest
doses of ionophore appeared to be toxic, as they prevented full
activation of MAPK. The toxic effect (total inhibition of JNK
activation) by 3 mM or greater ionomycin was observed in
three separate experiments.
Activation of JNK following Ang II stimulation is dependent
upon increases in intracellular calcium. Ang II-dependent
increases in tyrosine phosphorylation (26) and JNK activation
(see Fig. 5 and 6) were mimicked by thapsigargin and iono-
phore treatment. Since increased tyrosine kinase activity fol-
lowing Ang II, thapsigargin, or ionophore stimulation is inhib-
ited by intracellular or extracellular calcium chelation (24, 26),
we sought to determine if JNK activation was also calcium
dependent. Three approaches were used: (i) incubation of cells
with BAPTA-AM, a membrane-permeable calcium chelator,
(ii) a 30-min incubation with thapsigargin in the presence of
EGTA, a treatment that depletes intracellular calcium stores,
and (iii) incubation of cells with EGTA prior to ionophore
treatment.
TPA-treated (18 h) GN4 cells were incubated for 10 min
with 25, 50, 75, and 100 mM BAPTA-AM and then stimulated
with Ang II, A23187, ionomycin, or thapsigargin. The ace-
toxymethyl ester of BAPTA can enter the cell, where the ester
moiety is cleaved, leaving BAPTA to chelate intracellular cal-
cium. BAPTA-AM (25 to 50 mM) was sufficient to block both
Ang II-induced calcium transient and subsequent increases in
tyrosine kinase activity in GN4 cells (24, 26). Surprisingly,
BAPTA-AM treatment of GN4 cells resulted in a dose-de-
pendent activation of JNK, particularly at 75 to 100 mM
BAPTA-AM (Fig. 7); presumably, a toxic effect of BAPTA-AM
is responsible. When GN4 cells were treated with agonists that
raise intracellular calcium (Ang II, thapsigargin, and iono-
phore), JNK was activated 100- to 300-fold. Treatment with
BAPTA-AM at 25 to 50 mM reduced the response to calcium
ionophores by approximately 90% and the response to Ang II
and thapsigargin by up to 60 to 70% (Fig. 7). The inhibition by
BAPTA-AM was relatively specific; BAPTA-AM pretreat-
ment, at concentrations sufficient to block a rise in intracellular
calcium and to inhibit Ang II-dependent JNK activation, did
not block activation of JNK by UV irradiation (100 J/m2) (data
not shown). The failure to fully block Ang II and thapsigargin-
induced JNK activation with BAPTA-AM was seen consis-
tently in all experiments and indicates either that Ang II and
thapsigargin have calcium-independent as well as calcium-de-
pendent mechanisms for JNK activation or that there is a
complex interaction between low-dose BAPTA and Ang II
with respect to basal JNK activity.
To further examine the Ca21 dependence of Ang II-induced
JNK activation, GN4 cells were incubated with thapsigargin
and EGTA for 30 min prior to Ang II stimulation. Depleting
intracellular calcium reduced the response to Ang II by 50%,
similar to the 60% reduction in Ang II-stimulated JNK acti-
vation by BAPTA (data not shown). Moreover, when extracel-
lular calcium was chelated with EGTA before addition of
A23187 or ionomycin, JNK activation was reduced by greater
than 90% (data not shown).
Calcium-dependent activation of JNK is not mediated via
calmodulin but is inhibited by genistein. A major mechanism
for calcium signal transduction is via the large class of enzymes
activated by calcium and calmodulin, including the calcium/
calmodulin-dependent protein kinase II (see reference 21 for a
review). In order to determine if calmodulin mediates Ang II
activation of JNK, GN4 cells were incubated with two well-
studied calmodulin inhibitors at concentrations sufficient to
block the activation of calcium calmodulin kinase II. Incuba-
tion with W7 (10 to 40 mM) or calmidazolium (7.5 to 20 mM)
failed to inhibit Ang II-dependent JNK activation (Fig. 8) or
MAPK activation (data not shown). When GN4 cells were
treated with Ang II, an increase in calcium calmodulin-depen-
dent kinase II was detected, as assessed by phosphorylation of
a pseudosubstrate peptide (autocamtide 3) in an in vitro kinase
assay (20). Incubation of GN4 cells with W7 (25 to 40 mM) and
calmidazolium (10 to 20 mM) prior to Ang II stimulation
blocked this increase in calcium calmodulin kinase II activity
(data not shown), suggesting that W-7 and calmidazolium in-
hibit calmodulin-dependent processes at doses that do not
block JNK activation.
In contrast to the lack of efficacy of calmodulin inhibitors,
genistein (100 to 300 mM) consistently inhibited the activation
of JNK by Ang II or thapsigargin (Fig. 9A). In four experi-
ments, the activation of JNK was inhibited by 50 to 100 mM
genistein and was abolished by 300 to 400 mM genistein. Par-
allel assessment of MAPK in these and other experiments
(e.g., Fig. 2) showed that genistein also blocked MAPK acti-
vation by either Ang II or EGF. Figure 9B shows that incuba-
tion of GN4 cells with 300 mM genistein blocked Ang II- and
EGF-dependent tyrosine phosphorylation.
FIG. 7. JNK activation is calcium dependent. TPA-treated cells were incu-
bated (30 min) with the indicated concentrations of BAPTA-AM (25 to 100 mM)
and then stimulated (30 min) with vehicle, Ang II (1 mM), A23187 (10 mM),
ionomycin (1 mM), or thapsigargin (1 mM). JNK activation was assessed as
described in Materials and Methods and quantitated by phosphorimage analysis.
Activation is expressed as fold activation over that in vehicle-treated cells.
FIG. 8. JNK activation is not mediated by calmodulin. TPA-treated cells
were incubated with the indicated concentrations of W7 and calmidazolium (5
min) or vehicle and then stimulated with Ang II (1 mM, 30 min). Control cells (C)
were incubated without inhibitor. JNK activity was assessed as described in
Materials and Methods.
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DISCUSSION
Growth control is a complex process regulated in a cell
type-specific manner by a number of receptor classes. Most
studies emphasize the transmembrane growth factor receptors
bearing intrinsic tyrosine kinases (e.g., EGF and platelet-de-
rived growth factor [PDGF] receptors), but in many cell types,
members of the cytokine receptor family or G-protein-coupled
receptors modulate proliferation. The role of calcium as an
intracellular signal mediating proliferation by various receptor
classes has been debated for several years, in part because its
role may vary from cell type to cell type. A number of authors
have linked cell growth and calcium signals (see references 2
and 61 for reviews). However, elimination of the phospho-
lipase C activation by mutation of its specific SH2 docking site
on the EGF and fibroblast growth factor receptors does not
significantly alter EGF- and fibroblast growth factor-induced
mitogenesis (6, 44, 48). In contrast, an extensive study of
PDGF receptor signaling via SH2-containing proteins does
support a role for phospholipase C activation in PDGF-depen-
dent growth in certain cells (60). Prevention of a serum-in-
duced rise in calcium with BAPTA inhibited proliferation in
fibroblasts (61), and a role for G-protein-linked receptors that
elevate intracellular calcium has been firmly established during
in vivo growth of liver cells (liver regeneration following partial
hepatectomy) (10, 41, 50). Therefore, calcium appears to play
a role in the growth of some, but perhaps not all, cells.
Whatever the stimulus, diverse growth-signaling pathways
appear to converge on MAPK family members and the imme-
diate-early gene response. Recent data show a multiplicity
within members and regulation of the MAPK pathway. Cell
type specificity may play a role in regulation of MAPKs by the
dual-specificity kinases (MEKs and SEKs) that control the
MAPKs. For example, in mammals alone, more than five
members of the MAPK family, four members of the MEK/
SEK family, and three to four members of the MEKK family
have recently been identified or postulated (4, 11, 54, 65).
While the precise role of each subfamily or isoform is still
being clarified, these enzymes provide the flexibility for differ-
ential activation of transcription by different factors (e.g., c-
Fos, c-Jun, and ATF-2) and in different cell types. This manu-
script reports a novel cell type-specific regulatory pathway,
calcium-dependent JNK activation, which may be modulated
via a calcium-regulated tyrosine kinase.
Our initial observation of calcium-dependent tyrosine phos-
phorylation resulted from studies of the Ang II and EGF
receptors in rat liver epithelial cells. In intact cells, Ang II and
its calcium signal activate a cytosolic tyrosine kinase, producing
an activated, tyrosine-autophosphorylated kinase within 15 to
30 s of hormone addition. Although activation requires a cal-
cium signal, the tyrosine kinase(s) is not directly activated by
calcium in cell lysates, implying that its regulation involves
intermediaries. We have used antibodies, expression cloning,
and degenerate PCR techniques to identify 20 different ty-
rosine kinases in rat liver epithelial cells, but none of the
identified kinases appears to be the cytosolic calcium-regulated
enzyme. Most notably, the soluble p125FAK is not the major
calcium-regulated kinase activity in these cells, although FAK
is tyrosine phosphorylated and slightly (50%) activated by Ang
II. In other experiments, we have used antisera to JAK1,
JAK2, and JAK3 to demonstrate that none of these enzymes
are activated in Ang II-treated rat liver epithelial cells. (un-
published results). We have purified the major calcium-regu-
lated activity, a tyrosine-phosphorylated protein of 115 to 120
kDa with significant tyrosine kinase activity. We have sepa-
rated this putative novel tyrosine kinase from p125FAK and
hope in the future to determine whether this kinase is specif-
ically involved in the JNK activation pathway.
The demonstration that Ang II stimulated tyrosine phos-
phorylation and proliferation in these cells (25) led us to in-
vestigate the effect of Ang II on traditional signaling pathways
associated with proliferation. In this paper, we demonstrate
that Ang II increases AP-1 binding as well as MAPK and JNK
activity independent of PKC. The increases in AP-1 binding
and MAPK and JNK activity temporally followed activation of
a calcium-dependent tyrosine kinase. Genistein, in concentra-
tions sufficient to inhibit the calcium-dependent tyrosine ki-
nase, prevented Ang II-dependent activation of MAPK and
JNK. While not extensively studied, genistein at these concen-
trations does not appear to directly inhibit the kinase activity
of MEK (64), the dual-specificity kinase homologous to the
JNK-activating SEK. Thus, it is reasonable to assume that
genistein’s inhibition of Ang II-induced JNK activation impli-
cates a tyrosine kinase in this pathway.
Activation of JNK is independent of typical PKC isoforms.
Ang II stimulation leads to activation of phospholipase Cb,
resulting in increased inositol 1,4,5-triphosphate and diacylg-
lycerol. Subsequent elevations in diacylglycerol and calcium
activate various PKC isoforms, and diacylglycerol alone can
stimulate other PKC isoforms (46, 58). To determine if PKC is
involved in Ang II-induced JNK activation, we treated cells
with TPA, which downregulates TPA-sensitive PKCs. The data
are definitive: TPA-sensitive PKCs are not involved in activa-
tion of JNK by Ang II; however, PKC z and l are not activated
by phorbol esters and would not be downregulated by TPA
treatment (37). Thus, our experiments do not preclude involve-
ment of TPA-insensitive isoforms. The Ang II-dependent JNK
activation is slower (barely detectable at 5 min, detectable at 15
min, and maximal at 30 to 45 min) than Ang II activation of
FIG. 9. JNK activation requires the action of tyrosine kinases. (A) TPA-
treated cells were incubated with the indicated concentrations of genistein or
vehicle (5 min) and then stimulated (30 min) with Ang II (1 mM) or thapsigargin
(1 mM). JNK activation was assessed as described in Materials and Methods. (B)
Activation of a tyrosine kinase following Ang II stimulation is inhibited by
genistein. Cells were incubated with the indicated concentrations of genistein or
vehicle (—) for 15 min and then stimulated (1 min) with Ang II (1 mM) or EGF
(300 ng/ml). Lysates were subjected to immunoblotting with monoclonal an-
tiphosphotyrosine antibody as described in Materials and Methods.
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either tyrosine kinase (15 to 60 s) or MAPK (1 to 5 min). The
slow JNK response to Ang II suggests that this pathway in-
volves more (or decidedly slower) steps than the MAPK path-
way. JNK activation by TNFa is also slower than the initial
TNFa ceramide signaling (63). Current evidence suggests that
the final steps for some JNK activators involve stimulation of
MEKK (43, 65) and SEK/JNKK (36, 54). Whether cytokine- or
calcium-dependent processes use the same or different up-
stream regulators remains to be determined, as does the rea-
son for the slower JNK response to Ang II. However, the time
lag between Ang II-dependent MAPK and JNK activation
presumably does provide flexibility in regulation and duration
of the transcriptional response.
Calcium dependence of JNK activation by Ang II. Since
others had not observed activation of JNK by calcium iono-
phore in lymphocytes and several test cell lines (59), a key
question was whether this PKC-independent action of Ang II
was mediated by an inositol 1,4,5-triphosphate-induced intra-
cellular calcium signal. These data strongly suggest that Ang
II-dependent JNK activation in GN4 cells is in part calcium
dependent. First, Ang II as well as other G-protein-coupled
receptors that raise intracellular calcium (e.g., norepinephrine
and vasopressin) activate JNK. Second, thapsigargin, which
increases intracellular calcium and activates a calcium-regu-
lated tyrosine kinase in GN4 cells, generally stimulates JNK 50
to 75% as well as Ang II. Third, calcium ionophores activate
JNK with the same time course and with the same efficacy as
Ang II. Activation of JNK by ionophore is clearly calcium
dependent because this effect is blocked by the calcium chela-
tors EGTA and BAPTA-AM. However, the calcium signal
produced by ionophore is generally greater in magnitude and
duration than that produced by Ang II, and we cannot rule out
a toxic or ‘‘stress’’ effect of the prolonged calcium signal as
adjunctive to ionophore activation of JNK. Fourth, the effects
of Ang II and thapsigargin are significantly inhibited by
BAPTA-AM. While useful, the BAPTA-AM experiments
point out potential pitfalls in the use of cell-permeable chela-
tors as a sole criterion for calcium dependence. BAPTA-AM
treatment alone resulted in increases in JNK activation, espe-
cially at higher doses. Nevertheless, at lower doses,
BAPTA-AM clearly attenuated the effect of Ang II and thap-
sigargin but did not inhibit stress activation of JNK by UV
irradiation of GN4 cells. Furthermore, depletion of intracellu-
lar calcium stores by thapsigargin and EGTA treatment also
inhibited but did not totally abolish the effect of Ang II. This
leaves open the possibility of a calcium-independent compo-
nent of the Ang II-dependent JNK activation (perhaps by
signaling via the bg subunits of the heterotrimeric G-protein
activated by Ang II). However, taken together, these data
provide strong evidence that Ang II-dependent JNK activation
is at least partly calcium dependent.
In contrast, the calcium dependence of Ang II’s stimulation
of MAPK in GN4 cells was less definitive. Ang II is a reason-
able activator of MAPK in GN4 cells, being approximately
50% as efficacious as EGF, and others have shown that Ang II
or other G-protein-coupled receptors increase in MAPK ac-
tivity in several cell types (13, 28, 33, 42, 45, 47, 51). While
thapsigargin activates JNK to 50 to 75% of the level stimulated
by Ang II, Ang II is much more effective in activating MAPK
than is thapsigargin. Additionally, BAPTA’s effect on Ang
II-dependent MAPK activation was less definitive than its ef-
fect on JNK. BAPTA alone stimulated MAPK activity almost
as well as Ang II (unpublished results). Mechanisms other than
calcium have been suggested for G-protein-linked receptor
activation of MAPK, e.g., release of the bg subunits from the
heterotrimeric G-protein, which may activate the Ras pathway
by an unknown mechanism (8, 27, 31). The Ang II activation of
MAPK appears to be less calcium dependent than that of JNK
in GN4 cells, implying that MAPK activation by Ang II in-
volves components in addition to calcium.
JNK activation: multiple cell type-specific pathways? The
rapidly growing literature on JNK indicates that it is most
potently activated by pathways other than traditional growth
factor receptor tyrosine kinases. The strongest activators, UV
irradiation and TNFa, as well as stresses such as hydrogen
peroxide and heat shock involve signal transduction pathways
that fail to fully activate MAPK (32, 62). The pathway to JNK
activation by these diverse stimuli has not been fully elucidated
but does not universally involve calcium as a single stimulus.
For example, UV irradiation activates JNK in lymphocytes, but
the calcium ionophore A23187 alone does not activate JNK.
(However, ionophore with TPA was synergistic in lymphocytes
in JNK activation.) Calcium ionophore also failed to elevate
JNK activity in several fibroblasts and epithelial cell lines
tested (59).
In contrast to the failure of ionophores as a single agent to
stimulate JNK in lymphocytes, ionophores produced up to a
200-fold activation of JNK in GN4 cells. Ang II and thapsigar-
gin produce similar activation. Our hypothesis is that the ex-
pression of a calcium-regulated tyrosine kinase in liver epithe-
lial cells can link a calcium signal to the JNK activation
pathway. The corollary suggests that the calcium-regulated ki-
nase is not present or acts in a different manner in lymphocytes
and in some other cell lines. While proof of this hypothesis will
require isolation and subsequent expression of the calcium-
regulated tyrosine kinase(s), the supporting evidence (albeit
circumstantial) can be summarized as follows: (i) Ang II acti-
vates a tyrosine kinase and JNK in a PKC-independent, calci-
um-dependent manner; (ii) thapsigargin and ionophore stim-
ulate both the calcium-regulated tyrosine kinase and JNK
activity; (iii) activation of the calcium-regulated tyrosine kinase
and JNK by these agonists does not involve a calmodulin-
dependent pathway; and (iv) activation of both the calcium-
regulated tyrosine kinase and JNK is inhibited by genistein.
While the manuscript was in preparation, another group
reported that Gq-coupled muscarinic acetylcholine receptors
overexpressed in NIH 3T3 cells can activate JNK. This work
did not examine the calcium dependence of this effect (7).
Whether a calcium-regulated tyrosine kinase is involved or not,
the present data define a novel means for JNK activation in
certain cell types, a G-protein-mediated, calcium-dependent,
PKC-independent process that acts via a mechanism other
than calmodulin. Further studies should define the role of the
calcium-regulated tyrosine kinase in JNK and MAPK activa-
tion as well as its role in cell type-specific growth regulation.
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